Functional Reprogramming of a Marine Natural Product Enables Broad-Spectrum Anti- Pyroptotic Therapy for Intervertebral Disc Degeneration

Abstract Background Pyroptosis contributes to intervertebral disc degeneration, yet its interplay with oxidative stress may limit the efficacy of single-target interventions. This study aimed to identify a marine-derived anti-pyroptotic compound and expand its therapeutic potential through functional reprogramming. Results Single-cell transcriptomic analysis of human nucleus pulposus tissues revealed state-dependent enrichment of pyroptosis-associated programs during cellular remodeling, highlighting NLRP3 as a potential therapeutic target. Phenotype-based screening of marine natural products identified 5-[(1H-indol-3-yl) methylidene] imidazolidine-2,4-dione (IMH) as a selective inhibitor of NLRP3-associated pyroptosis. Multidimensional target validation confirmed direct IMH–NLRP3 binding and identified key residues contributing to their interaction. To overcome the pathway selectivity and limited antioxidant capacity of IMH, we functionally reprogrammed it into ruthenium-containing carbon dots and introduced platelet/nucleus pulposus cell hybrid membrane camouflage, generating Fm-IMH-CDs. This reprogramming preserved NLRP3 engagement while conferring multienzyme-mimetic regulation of reactive oxygen species and preferential recognition of pyroptotic nucleus pulposus cells. Fm-IMH-CDs suppressed oxidative stress, mitochondrial dysfunction, inflammatory signaling, and pyroptotic injury across multiple inflammatory contexts, accompanied by modulation of NOD-like receptor and nuclear factor κB signaling. In a rat model of intervertebral disc degeneration, Fm-IMH-CDs prolonged intradiscal retention, preserved nucleus pulposus architecture and extracellular matrix, reduced pyroptosis-associated inflammation and matrix catabolism, and attenuated disc degeneration. Conclusions Functional reprogramming transforms a pathway-selective marine natural product into a multifunctional biomimetic nanoplatform integrating molecular targeting, redox regulation, and preferential cellular recognition. This strategy offers a promising approach for broader anti-pyroptotic intervention in intervertebral disc degeneration.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-16
DOI
https://doi.org/10.21203/rs.3.rs-11424447/v1
Primary Topic
Spine and Intervertebral Disc Pathology
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Functional Reprogramming of a Marine Natural Product Enables Broad-Spectrum Anti- Pyroptotic Therapy for Intervertebral Disc Degeneration

Linhui Han, Jialin Li, Xiaowei Luan, Haisong Yang et al.
3 links
Research Square
Spine and Intervertebral Disc Pathology
preprint

Functional Reprogramming of a Marine Natural Product Enables Broad-Spectrum Anti- Pyroptotic Therapy for Intervertebral Disc Degeneration

Linhui Han, Jialin Li, Xiaowei Luan, Haisong Yang, Tingfei Yan, Wenbo Lin, Rui Zhang², Wei Li¹
preprint en

Abstract

Abstract Background Pyroptosis contributes to intervertebral disc degeneration, yet its interplay with oxidative stress may limit the efficacy of single-target interventions. This study aimed to identify a marine-derived anti-pyroptotic compound and expand its therapeutic potential through functional reprogramming. Results Single-cell transcriptomic analysis of human nucleus pulposus tissues revealed state-dependent enrichment of pyroptosis-associated programs during cellular remodeling, highlighting NLRP3 as a potential therapeutic target. Phenotype-based screening of marine natural products identified 5-[(1H-indol-3-yl) methylidene] imidazolidine-2,4-dione (IMH) as a selective inhibitor of NLRP3-associated pyroptosis. Multidimensional target validation confirmed direct IMH–NLRP3 binding and identified key residues contributing to their interaction. To overcome the pathway selectivity and limited antioxidant capacity of IMH, we functionally reprogrammed it into ruthenium-containing carbon dots and introduced platelet/nucleus pulposus cell hybrid membrane camouflage, generating Fm-IMH-CDs. This reprogramming preserved NLRP3 engagement while conferring multienzyme-mimetic regulation of reactive oxygen species and preferential recognition of pyroptotic nucleus pulposus cells. Fm-IMH-CDs suppressed oxidative stress, mitochondrial dysfunction, inflammatory signaling, and pyroptotic injury across multiple inflammatory contexts, accompanied by modulation of NOD-like receptor and nuclear factor κB signaling. In a rat model of intervertebral disc degeneration, Fm-IMH-CDs prolonged intradiscal retention, preserved nucleus pulposus architecture and extracellular matrix, reduced pyroptosis-associated inflammation and matrix catabolism, and attenuated disc degeneration. Conclusions Functional reprogramming transforms a pathway-selective marine natural product into a multifunctional biomimetic nanoplatform integrating molecular targeting, redox regulation, and preferential cellular recognition. This strategy offers a promising approach for broader anti-pyroptotic intervention in intervertebral disc degeneration.

Research Square
Shanghai University (CN), Second Military Medical University (CN)
Good health and well-being
Spine and Intervertebral Disc Pathology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon